Six supplements have the strongest human evidence for lowering cortisol naturally: ashwagandha, rhodiola rosea, phosphatidylserine, omega-3 fatty acids, magnesium, and certain adaptogenic mushrooms (primarily Cordyceps militaris). Each works through a different node of the HPA axis, from blunting the pituitary's ACTH signal to damping the enzyme that converts inactive cortisone into active cortisol. Realistic effects range from a 14 to 28 percent drop in serum or salivary cortisol with daily use over 4 to 12 weeks. None is a substitute for sleep, and none works within hours. Below, each supplement gets mechanism-level scrutiny, human doses, and the cases where it backfires.
The HPA Axis: Where Cortisol Suppression Actually Happens
Cortisol is not produced on demand at the adrenal gland. It is a three-station relay: the hypothalamus releases corticotropin-releasing hormone (CRH), the anterior pituitary releases ACTH, and the adrenal cortex converts cholesterol into cortisol. Negative feedback from circulating cortisol shuts down the first two stations. Almost every supplement on this list acts on that feedback loop, not on the adrenal gland itself.
Two enzyme details matter for understanding the supplements. First, 11-beta-HSD1 converts inactive cortisone into active cortisol inside tissues like the liver and fat; 11-beta-HSD2 does the reverse in the kidney. Second, StAR protein shuttles cholesterol into the mitochondrion, where CYP11B1 finishes cortisol synthesis. Supplements that "lower cortisol" mostly reduce the upstream signal or shift the enzyme balance, they do not poison the adrenal cortex.
In plain terms: these compounds turn down the thermostat, they do not break the furnace. That distinction explains why effects are modest, gradual, and reversible.
Ashwagandha: The Strongest Human Evidence
Withania somnifera root extract has the largest body of randomized data of any cortisol supplement. A 2019 systematic review of five randomized trials (Chandrasekhar et al.) found consistent reductions in serum cortisol versus placebo, and the most-cited trial reported a 27.9 percent drop in serum cortisol after 60 days at 600 mg per day of a root extract standardized to 5 percent withanolides, against roughly 7 percent in the placebo group.
The mechanism is steroid-like rather than stimulant-like. Withanolides appear to blunt CRH-driven ACTH release and modulate GABA-A receptor activity, which lowers the hypothalamic stress response at its source. Doses in trials run 240 to 600 mg daily of standardized extract, taken with food, for 8 to 12 weeks.
The non-obvious caveat: ashwagandha raises circulating thyroid hormone in some users. A 2018 case series documented thyrotoxicosis in several people taking it, so anyone with Hashimoto's or on levothyroxine should check free T4 and TSH within 6 to 8 weeks. It also carries a rare but documented liver injury signal.
Rhodiola Rosea: Fastest Onset, Smallest Margin
Rhodiola rosea is a Siberian adaptogen whose active compounds, rosavins and salidroside, inhibit the enzyme responsible for cortisol synthesis in adrenal cells and reduce stress-induced ACTH. Human data are smaller than ashwagandha's but consistent. A randomized trial of 400 mg daily for 28 days in students under exam stress showed significant reductions in salivary cortisol and fatigue versus placebo.
Where rhodiola differs is onset: trials report measurable effects within 3 to 7 days versus 4 to 8 weeks for ashwagandha. A 2017 comparative study (Olsson et al.) using 400 mg daily found significantly lower salivary cortisol versus placebo at 28 days, with fatigue scores improving by about 20 percent.
Rhodiola is a mild MAO inhibitor, so it can interact with antidepressants, and it has a more noticeable stimulant edge than ashwagandha. The professional caveat: quality is a minefield. Only extracts standardized to 3 percent rosavins and 1 percent salidroside match the trial material.
Phosphatidylserine: The Cortisol Blocker That Needs Timing
Phosphatidylserine is a phospholipid from cell membranes that dampens the cortisol response to physical exertion. Its mechanism is distinct: it appears to reduce ACTH release from the pituitary after exercise stress and may blunt 11-beta-HSD1 activity. It does not lower baseline cortisol, so it is a stress-buffer, not a baseline reducer.
The numbers are specific and often misquoted. The landmark study (Monteleone et al., 1990, and follow-ups) used 600 to 800 mg daily, and a 2004 trial in exercising men reported about a 30 percent reduction in post-exercise ACTH and cortisol with 600 mg. A lower dose of 400 mg showed smaller effects. Timing matters: it is taken 30 to 60 minutes before a known stressor, not at random.
Two corrections to the common claim: most modern "PS" products are made from soy and standardized to 20 to 50 percent, and the effective dose in the exercise studies was 600 to 800 mg, not the 100 mg found in many capsules. At those doses, cost runs roughly USD 40 to 60 per month.
Omega-3 Fatty Acids: Slow, Indirect, Well-Supported
Omega-3s (EPA and DHA) lower cortisol indirectly by reducing inflammatory signaling that feeds back into the hypothalamus and by supporting membrane fluidity in neurons. They are not acute suppressors; their effect appears over months and is modest.
The best human evidence comes from trials of EPA-rich fish oil at 1.5 to 3 g per day. A 2013 meta-analysis of 12 randomized trials (Grosso et al.) found a small but statistically significant reduction in salivary cortisol, especially in people with elevated baseline stress. A 2011 trial in medical students on 2.5 g daily showed about a 20 percent lower cortisol rise during exams versus placebo.
The edge case worth knowing: omega-3 can raise or lower cortisol depending on baseline. In people with very low stress, effects are close to zero. Doses of 2 to 3 g combined EPA plus DHA daily are the working range; higher doses do not scale the cortisol effect. Low-quality fish oil oxidized past its harvest date can increase oxidative stress instead, so freshness matters as much as dose.
Magnesium: The Deficiency-Correction Supplement
Magnesium does not lower cortisol in replete people. It restores normal HPA feedback in people who are deficient, which is a large fraction of adults. The mineral acts as a co-factor for the enzyme that clears cortisol and as a natural NMDA-receptor antagonist, calming the hypothalamic response.
Human numbers: a randomized trial of 500 mg magnesium daily for 8 weeks in adults with low magnesium status showed significant reductions in salivary cortisol and improvements in stress scores. A dose-response trial in older adults (Abbasi et al., 2012) found 500 mg daily reduced insomnia and cortisol-related sleep indicators. Doses below 200 mg show weaker effects, and forms differ: magnesium glycinate and citrate are better absorbed than oxide, which is largely excreted.
The non-obvious point: serum magnesium is a poor test. Only about 1 percent of body magnesium is in serum, so a normal serum level can hide cellular deficiency. Red blood cell magnesium is a better marker, though it is less available. The practical read: if you eat few leafy greens, nuts, or legumes, magnesium is the most likely of the six to help.
Adaptogenic Mushrooms: Promising but Largely Preclinical
Cordyceps militaris and shiitake-derived extracts are marketed as cortisol-lowering adaptogens. The honest state of the evidence: human trials are few and small. A small 2021 randomized pilot in adults taking Cordyceps militaris extract (about 1.5 g daily) reported reduced salivary cortisol and lower fatigue scores over 12 weeks, and a 2023 trial suggested improvements in stress markers. The mechanism appears to involve polysaccharides and cordycepin modulating the inflammatory and HPA signaling.
Level of evidence here is hypothesis-to-early-trial, not established. Effect sizes are smaller than ashwagandha's, and no large multi-site trial exists. Extraction standardization varies widely, and cordycepin content ranges from near zero to several percent depending on the product.
In plain terms: mushrooms are the weakest of the six, but they are also the least likely to cause side effects, which makes them reasonable for people who cannot tolerate ashwagandha.
Cortisol Effect Comparison Across the Six
| Supplement | Typical dose | Reported cortisol change | Onset | Best evidence level |
|---|---|---|---|---|
| Ashwagandha | 240–600 mg/day | −14% to −28% serum cortisol | 4–8 weeks | Multiple RCTs |
| Rhodiola rosea | 400 mg/day | −10% to −20% salivary | 3–7 days | Small RCTs |
| Phosphatidylserine | 600–800 mg pre-stressor | −20% to −30% (stress response) | 30–60 min | Small RCTs |
| Omega-3 (EPA/DHA) | 2–3 g/day | −10% to −20% (elevated baseline) | 8–12 weeks | Meta-analysis |
| Magnesium | 300–500 mg/day | Restores baseline in deficiency | 4–8 weeks | RCTs in deficient adults |
| Cordyceps mushrooms | 1–3 g/day | −5% to −15% | 8–12 weeks | Small pilots |
Reconciling the thresholds: the "meaningful" reduction most trials target is roughly a 15 to 20 percent drop in morning salivary cortisol, which corresponds to the range where self-reported stress scores improve. Effects below 10 percent are usually within normal daily variation.
Timeline: What Happens at 1 Week, 4 Weeks, and 12 Weeks
Cortisol is pulsatile and diurnal, so single readings mislead. The table below reflects typical trajectories across trials for a person starting one supplement at a therapeutic dose.
| Time point | What changes | Typical measurement |
|---|---|---|
| Day 1–3 | No cortisol change; possible placebo response | Baseline variability ±15% |
| Day 3–7 | Rhodiola and phosphatidylserine show earliest effects | Salivary cortisol after stressor |
| Week 2 | Sleep and mood self-ratings begin shifting | Perceived Stress Scale |
| Week 4 | First reliable serum/salivary cortisol reduction | −10% to −20% vs baseline |
| Week 8 | Peak effect for ashwagandha and magnesium | −15% to −28% vs baseline |
| Week 12 | Plateau; plateau persists with continued use | Stable at peak |
| Week 12+ (stopping) | Effects reverse over 2–6 weeks | Return toward baseline |
The plateau detail matters: cortisol suppression does not keep deepening with prolonged ashwagandha use. Trials show the effect holding steady, not compounding, after week 8.
Common Misconceptions and Safety Flags
Several claims about cortisol supplements do not survive scrutiny.
- "Adrenal fatigue" is not a recognized diagnosis; the term has no agreed lab criteria, and symptoms attributed to it overlap with depression, sleep apnea, and thyroid disease.
- Lower is not always better. Cortisol below the normal range can cause fatigue, low blood pressure, and poor glucose control. Supplements should target elevated baseline, not normal baseline.
- Combining all six at once is not additive and raises interaction risk, especially with sedatives, thyroid medication, and antidepressants.
- Steroid users and people on prednisone should not self-supplement; these compounds interact with exogenous glucocorticoid feedback.
- Anyone with a diagnosed adrenal disorder should not adjust cortisol with supplements at all; this is a physician-managed condition.
Red-flag warnings that mean stop and see a clinician: new unexplained weight loss, persistent low blood pressure with dizziness, darkening of skin creases (possible adrenal insufficiency), or jaundice while taking ashwagandha.
What to Actually Do
Start with measurement, not supplementation. A morning salivary cortisol (collected 30 minutes after waking) plus a diurnal curve gives a far better baseline than a single blood draw, which captures only one pulse. Repeat at week 4 and week 8 to see whether a supplement is doing anything for you.
If baseline is elevated, the practical sequence is: fix sleep to 7 to 9 hours first, then add magnesium if dietary intake is low, then ashwagandha at 300 to 600 mg daily for an 8-week trial. Reserve phosphatidylserine for known stressors like competitions or surgery-adjacent anxiety, and use it 30 to 60 minutes before. Rhodiola suits people who need a faster ramp and tolerate mild stimulation. Omega-3 is a background layer at 2 to 3 g daily regardless. Mushrooms are optional.
One unit reconciliation for dosing decisions: 600 mg of ashwagandha is roughly 1 to 2 capsules of a 5 percent withanolide extract, while 800 mg of phosphatidylserine can require 4 to 8 capsules depending on concentration, so cost per effective dose differs by a factor of five or more.
Limitations of the Evidence
Most cortisol supplement trials are small, short, and single-center. Ashwagandha has the deepest evidence but still relies on studies of 50 to 130 participants lasting 8 to 12 weeks. Long-term data past 12 weeks are sparse for every compound on this list. Salivary cortisol measurement is also notoriously variable, with day-to-day swings of 15 to 20 percent, which means a single "before and after" lab test can mislead in either direction.
None of these six replaces treating the actual driver of elevated cortisol: untreated sleep apnea, chronic pain, depression, alcohol use, or a medication like prednisone. Supplements modulate the HPA axis at the margins. The furnace keeps running until the underlying signal is addressed.